Sat, Dec 20, 2014, 1:14 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Array BioPharma, Inc. Message Board

  • prembhai44 prembhai44 May 7, 2013 10:36 PM Flag

    Arry needs cash and lots of it for its trials...... CASH IN KING.

    Expect another round of financing coming. They cannot sustain trials with limited cash on hand, I expect to see a diluting coming anytime. It was why she went down so hard today, everyone knows their cash at hand situation cannot take them to the finish line. Plain and simple , expect to hear about it soon before markets starts flattening

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Read the earnings transcript. Seems plenty of discussion going on re. partnering - "While we feel our cash position is healthy, we are focused, as I mentioned, on bringing additional sources of non-dilutive capital the way we prefer to fund the company, to support our development efforts".
      I recommend everyone should read the transcript. Exciting times ahead for Array.

      Sentiment: Strong Buy

4.86+0.06(+1.25%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST